“A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Long-Acting Injectable Formulation of Vanoxerine (Vanoxerine Consta 394.2 Mg) for Treatment of Amphetamine-Type Stimulant (ATS) Dependence”. London Journal of Medical and Health Research 24, no. 6 (July 8, 2024): 63–87. Accessed February 2, 2026. https://journalspress.uk/index.php/LJMHR/article/view/920.